Tirzepatide is for adults seeking a holistic approach to address concerns such as weight management. Our goal is to help customers improve their overall well-being through personalized, physician-endorsed therapy plans and on-going support from licensed healthcare providers, regardless of their specific age-related challenges.

There isn’t a simple answer to this question, as it depends on various factors including your starting weight, exercise levels, age, and gender.

However, if you’re curious about whether you’ll experience noticeable weight loss with Tirzepatide, the answer is a definite yes. Most patients on Tirzepatide see significant weight loss.

A study published in the New England Journal of Medicine demonstrated that Tirzepatide is effective for weight loss. The mean percentage change in weight at week 72 was −15.0% for the 5-mg dose, −19.5% for the 10-mg dose, and −20.9% for the 15-mg dose, compared to −3.1% for the placebo.

Additionally, the percentage of participants who experienced a weight reduction of 5% or more was significantly higher in the Mounjaro groups than in the placebo group. Notably, 50% and 57% of participants in the 10-mg and 15-mg groups, respectively, had a reduction in body weight of 20% or more, compared to only 3% in the placebo group.

As shown, the weight loss effects of Mounjaro are substantial, with those receiving the highest dosages experiencing weight loss of over 20%.

Tirzepatide injections can start to lower blood sugar levels immediately after the first dose. However, it typically takes about 8-12 weeks of consistent use to reach healthy blood sugar levels.

For those using Tirzepatide for weight loss, significant results are generally seen around 28 weeks.

It’s important to remember that while Tirzepatide can be an effective tool for weight loss, it works best when combined with healthy lifestyle changes such as improving your diet and increasing physical activity. These lifestyle changes can greatly enhance the results achieved with Tirzepatide.

Tirzepatide is a powerful starting point that can help you achieve your weight loss goals, but it won’t do all the work for you. It’s essential to put in the effort to maximize the treatment’s effectiveness.

Here are some tried and tested tips:

– Follow the program’s meal plans and exercise routines.
– Drink plenty of water.
– Ensure you get adequate rest and sleep.
– Utilize the coaching resources available to you.
– Maintain a positive mindset and focus on making progress rather than obsessing over reaching your perfect weight.

By adhering to the program, you will lose weight. While it won’t happen overnight, you might find that the results come sooner than you expect.

Insurance is not required to access our services and products. The cost of treatments may vary, but CHC aims to provide affordable and accessible solutions to customers without the need for insurance coverage.

Absolutely! We understand how life can change in an instant. There are no long-term contracts or cancellation fees here. You have the flexibility to cancel before your next prescription is submitted, about 10 days before your next payment.

To complete a consultation with Custom Health Centers, simply fill out our brief online medical questionnaire. Our medical team, based in the United States, will evaluate your responses to determine your suitability for treatment and the most appropriate medication for your needs.

Yes, we use plain packaging without any identifying labels or logos.

If you are eligible for treatment, our Medical Team will issue you a prescription. You do not need an outside prescription to work with us.

Compounded Drugs

Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Your Custom Health Centers-affiliated provider may recommend certain doses of compounded Tirzepatide based on your medical evaluation.

Warning: Risk of Thyroid C-Cell Tumors

In rats, Tirzepatide (known as Zepbound®) caused thyroid tumors, including thyroid cancer. It is not known if Tirzepatide will cause thyroid tumors or medullary thyroid carcinoma (MTC) in people. Inform your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath, as these may be symptoms of thyroid cancer.

Do not use Tirzepatide if you or any family member have had MTC or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is the FDA-approved use of Tirzepatide?

Tirzepatide is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

• 30 kg/m² or greater (obesity), or
• 27 kg/m² or greater (overweight) with at least one weight-related condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease).

Limitations of Use:

• Tirzepatide should not be used with other Tirzepatide-containing products or any other GLP-1 receptor agonist.
• The safety and efficacy of using Tirzepatide with other weight management products have not been established.
• Tirzepatide has not been studied in patients with a history of pancreatitis.

Who should not use Tirzepatide?

Do not use Tirzepatide if:

• You or any family member have had MTC or if you have MEN 2.
• You have a known allergy to Tirzepatide.

How should I take Tirzepatide?

Tirzepatide can be taken with or without food. The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your Custom Health Centers-affiliated provider will guide you on a treatment regimen that may include dose adjustments every four weeks.

Do not alter your dosing regimen or stop taking Tirzepatide without consulting your provider.

What should I tell my Custom Health Centers-affiliated provider before using Tirzepatide?

It’s important to inform your Custom Health Centers-affiliated provider of all medications you are taking, including prescription, over-the-counter, vitamins, and herbal supplements.

Be mindful of the following:

• Medications for diabetes: Including insulin or sulfonylureas (e.g., Amaryl, Glucotrol XL).
• Other oral medications: Tirzepatide may impact the absorption of oral medications due to delayed gastric emptying. Your provider can guide you on medication scheduling.
• Hormonal birth control: Tirzepatide may decrease the efficacy of oral contraceptives. Use a non-oral contraceptive method or a barrier method for 4 weeks after starting Tirzepatide and after each dose escalation until reaching a maintenance dose.
• Other GLP-1 medications: Including Mounjaro, Wegovy, Ozempic, Saxenda, Victoza, Byetta, or Bydureon. Do not take these with Tirzepatide.
• Weight loss products: Including dietary supplements.

Share your complete medical history, especially if you have:

• Type 1 or type 2 diabetes
• Thyroid cancer
• Gastrointestinal disease
• Pancreatitis
• Kidney disease
• Diabetic retinopathy
• Depression or suicidal thoughts

Notify your provider if you are pregnant, planning to become pregnant, or breastfeeding:

• Pregnancy: Tirzepatide should not be used during pregnancy due to potential risks to the unborn baby.
• Reproductive potential: Tirzepatide may reduce the efficacy of oral contraceptives. Use a non-oral contraceptive method or add a barrier method for 4 weeks after starting and after each dose escalation until reaching a maintenance dose.
• Breastfeeding: It is unknown if Tirzepatide passes into breast milk. Discuss the benefits and risks with your provider.

Pregnancy registry: A pregnancy exposure registry monitors outcomes in women exposed to Tirzepatide during pregnancy. Pregnant patients and healthcare providers can contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979).

Providing inaccurate health information to obtain treatment may result in harm, including death.

What are the most serious side effects to monitor for when taking Tirzepatide?

If you experience a medical emergency, call 911 or seek immediate medical attention.

These serious side effects are rare but can occur with Tirzepatide. Monitor for these, especially at the start of treatment or with dose changes:

• Thyroid C-Cell Tumors: Tirzepatide may increase the risk of thyroid tumors. Report any lumps or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
• Severe Gastrointestinal Disease: Tirzepatide can cause severe gastrointestinal side effects such as nausea, diarrhea, vomiting, constipation, and stomach pain.
• Acute Kidney Injury: Gastrointestinal side effects like diarrhea, nausea, and vomiting may cause dehydration, worsening kidney problems. Drink plenty of water to stay hydrated.
• Acute Gallbladder Disease: Tirzepatide and weight loss may increase the risk of gallbladder disease. Report pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.
• Acute Pancreatitis: Watch for severe abdominal pain that may radiate to the back, with or without vomiting.
• Allergic Reactions: Stop Tirzepatide if you experience symptoms such as facial swelling, severe rash, rapid heartbeat, breathing difficulties, or fainting.
• Low Blood Sugar (Hypoglycemia): Tirzepatide may lower blood glucose, causing hypoglycemia in patients taking other glucose control medications. Monitor blood sugar and watch for dizziness, blurred vision, mood changes, sweating, or rapid heartbeat.
• Diabetic Retinopathy Complications: Rapid glucose control improvement may temporarily worsen diabetic retinopathy. Report any vision changes.
• Suicidal Behavior and Ideation: Monitor for sudden changes in mood, behaviors, thoughts, or feelings. Contact your provider if mental health changes occur.
• Never Share a Pen: Sharing pens poses an infection risk.

What are the most common side effects of Tirzepatide?

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Stomach pain
• Indigestion
• Injection site reactions
• Feeling tired
• Allergic reactions
• Belching
• Hair loss
• Gastroesophageal reflux disease (heartburn)

Report negative side effects to the FDA: Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

This information is not comprehensive. Please see the full Prescribing Information for complete safety details.

Generic Compounded GLP medications we offer are obtained from compounded pharmacies.

The medication you may be prescribed is a generic compounded medication and is not associated with the Novo Nordisk™ company or the brand-name medications Saxenda®, Victoza®, Rybelsus ®, Wegovy® or Ozempic®. or any other medications that are registered with Novo Nordisk™.

We are also not affiliated with the Eli Lily™ Company or any of their brand medications like Mounjaro, Trulicity, or any other medications that are registered with Eli Lily™.